Geoffrey Lynn

Geoffrey Lynn

Company: Barinthus Biotherapeutics

Job title: Senior Vice President Synthetic Immunotherapies


Intramuscularly Administered SNAP-TI Nanoparticles Induce Systemic Antigen-Specific Tolerance 10:00 am

Introducing the SNAP-TI platform and mechanism of action in animal models of Type 1 Diabetes and Multiple Sclerosis Discussing the VTP-1000 drug product candidate based on SNAP-TI for celiac diseaseRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.